Yuliya Lytvyn

25PUBLICATIONS
59CO-AUTHORS
Molecular targetsAutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 12, 2025
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Vikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn

|May 22, 2024
Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions.

Richie Jeremian, Yuliya Lytvyn, Rayyan Fotovati

|Feb 25, 2023
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis.

Yuliya Lytvyn, Melinda Gooderham

|Nov 26, 2022
Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review.

Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula

Pageof 5